Progenics Pharmaceuticals Cultura de la Empresa

Mr. Jeffrey D. Summer also known as Jeff, has been Senior Vice President of Digital Technology at Progenics Pharmaceuticals, Inc. since October 18, 2017. Mr. Summer served as Senior Vice President of Strategy & Performance at Progenics Pharmaceuticals, Inc. since April 2016 until October 18, 2017 and also served as its Vice President of Organization & Talent since July 2015 until March 8, 2016. Mr. Summer facilitated company effectiveness through strategy implementation, organization design and talent development. His key experience includes nearly fourteen years as a Partner at Deloitte and later working as an Independent Consultant. While at Deloitte, along with leading the firm's global talent management practice, he served a two-year secondment as the U.S. Firms CHRO. He has worked with numerous companies in Healthcare including Pfizer, Financial Services including Goldman Sachs and Professional Services Baker & McKenzie. He received his bachelors degree in Psychology at Seattle University.

Dr. Vivien Wong, Ph.D. serves as Executive Vice President of Development at Progenics Pharmaceuticals, Inc. and served as its Executive Vice President. Dr. Wong served as Senior Vice President of Operations and Portfolio Management at Progenics Pharmaceuticals, Inc. Dr. Wong served as Vice President of Product Development at Progenics Pharmaceuticals Inc. She joined Progenics in September 2007. Prior to joining Progenics, Dr. Wong was Principal at Theritas Pharmaceutical Consultants from 2004 to 2007. From 1989 to 2004, Dr. Wong held positions of increasing responsibility in preclinical development and pharmacology at Emisphere Technologies, Vivoquest and Regeneron Pharmaceuticals. Dr. Wong serves on the International Advisory Board of the Molecular Neuroscience Center of Hong Kong University of Science and Technology. She received a B.Sc. in Biology from the Mississippi University for Women, a Ph.D. in Anatomy and Neurobiology from the University of Maryland School of Medicine and completed a postdoctoral fellowship in Neurology at the Albert Einstein College of Medicine.

Mr. Patrick Fabbio, also known as Pat, has been Senior Vice President and Chief Financial Officer of Progenics Pharmaceuticals, Inc. since November 16, 2015. Mr. Fabbio served as Chief Financial Officer of electroCore LLC (also known as electroCore Medical, LLC) where he developed the corporate finance strategy supporting additional financing in preparation for FDA approval and launch. Mr. Fabbio served as the Chief Financial Officer of Ikano Therapeutics Inc. since May 2009. During his three years with NPS, he led the build-out of the global finance department and supported the $5.2 billion sale to Shire plc in February 2015. Prior to NPS, he served in senior financial positions including Vice President of Finance of Catalent Pharma Solutions. Mr. Fabbio served as Senior Director of US Life Cycle Management & Base Business at sanofi-aventis, where he served senior financial, transactional and operational positions. He served as Vice President of Commercial Operations at Unipath Diagnostics, a division of Unilever and as Corporate Controller at Biomatrix. He began his career at Coopers & Lybrand. He is a Certified Public Accountant. Mr. Fabbio graduated BBA in Accounting from Pace University and earned an MBA in Finance from New York University.

Jeff Summer serves as the Senior Vice President, Digital Technology of Progenics Pharmaceuticals, Inc.. Jeff started at Progenics Pharmaceuticals, Inc. in Jan of 2017. Jeff currently resides in the Greater New York City Area.

Bryce Tenbarge serves as the Senior Vice President - Commercial of Progenics Pharmaceuticals, Inc.. Bryce started at Progenics Pharmaceuticals, Inc. in Mar of 2018. Bryce currently resides in the Greater New York City Area.

Gary Lunger serves as the Senior Director, Sales and Marketing of Progenics Pharmaceuticals, Inc.. Gary started at Progenics Pharmaceuticals, Inc. in Aug of 2017. Gary currently resides in the Greater New York City Area.

Nancy Stambler serves as the Executive Director, Biometrics of Progenics Pharmaceuticals, Inc.. Nancy started at Progenics Pharmaceuticals, Inc. in Apr of 2012. Nancy currently resides in the Greater New York City Area.

Jessica Jensen serves as the VP, Clinical Development of Progenics Pharmaceuticals, Inc.. Jessica started at Progenics Pharmaceuticals, Inc. in Sep of 2016. Jessica currently resides in the Greater New York City Area.